Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
Status:
Terminated
Trial end date:
2019-03-19
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare clinical efficacy and tolerability of valproic acid
(VPA) therapy versus dihydroergotamine (DHE) as abortive therapy in pediatric migraine.